Related Experiment Video
Updated: Feb 8, 2026

Identification of the Genes Involved in Stomatal Development via Epidermal Phenotype Scoring
Published on: January 20, 2023
Liver involvement in infants with PiSZ phenotype of alpha 1-antitrypsin deficiency
1Department of Paediatrics, Regional Hospital, Bozen, Bolzano, Italy.
Insights
Newborn screening identified PiSZ phenotype infants. While some showed temporary liver dysfunction, all infants normalized by 12 months, indicating no neonatal cholestasis signs.
Area of Science:
- Genetics
- Pediatrics
- Hepatology
Background:
- Alpha-1-antitrypsin (AAT) deficiency is a genetic disorder.
- The PiZ allele is associated with severe AAT deficiency and liver disease.
- The PiSZ phenotype represents a moderate AAT deficiency.
Purpose of the Study:
- To investigate the clinical and biochemical manifestations of the PiSZ phenotype in newborns.
- To assess liver function and identify any signs of neonatal cholestasis in PiSZ infants.
Main Methods:
- Newborn screening for protease inhibitor (Pi) phenotype.
- Clinical and biochemical follow-up of PiSZ infants at 2, 5, and 12 months.
- Liver biopsy in one case with persistent abnormal liver enzymes.
Main Results:
- 14 PiSZ infants were identified from 19,432 newborns.
- Three infants showed transient hepatic dysfunction at 2 and 5 months.
- All PiSZ infants had normal liver function tests by 12 months, with no signs of neonatal cholestasis.
Conclusions:
- The PiSZ phenotype in newborns is associated with transient, mild liver dysfunction.
- PiSZ infants do not typically present with neonatal cholestasis.
- Liver involvement in PiSZ phenotype is similar to PiMZ but with AAT levels like PiZZ.
Abstract:
Between July 1985 and June 1989, 19,432 newborns were screened during the first days of life to determine their Pi (protease inhibitor) phenotype. Fourteen infants were identified to be carriers of the PiSZ phenotype. Their clinical and biochemical follow-up data were recorded at 2, 5, and 12 months of age; only one case underwent a liver biopsy due to repeated abnormal liver enzymes. Three of 14 PiSZ infants showed some hepatic dysfunction at 2 and 5 months of age, but at 12 months all patients had normal liver function tests. None of them had clinical, biochemical, or morphological signs of neonatal cholestasis. The clinical and biochemical data related to the liver involvement are similar to those of the PiMZ phenotype, though the serum levels of alpha 1-antitrypsin in PiSZ carriers match those of the PiZZ group.
Related Concept Videos
Drug Dosing: Infants and Children
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and...
Liver Histology
Hepatocytes perform a variety of essential functions. They secrete...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Background and Environment Affect Phenotype
An example of how genetic background affects phenotype can be seen in horses. The Extension gene in horses is responsible for their coat color. A wild-type gene (EE) produces black pigment in the coat, while a mutant gene (ee) produces red pigment. A...

